Who founded Avenzoar Pharmaceuticals?

Avenzoar Pharmaceuticals was founded by Stephen Pandol in 2015.

How much funding has Avenzoar Pharmaceuticals raised?

Avenzoar Pharmaceuticals has disclosed $1.4M raised across 2 rounds.

Where is Avenzoar Pharmaceuticals headquartered?

Avenzoar Pharmaceuticals is headquartered in Encinitas, US.

Avenzoar Pharmaceuticals

Encinitas, US · Founded 2015 · California corporation

Avenzoar Pharmaceuticals is a pharmaceutical company developing therapies through its team of scientists and researchers. The page provides team information but limited detail on specific products or focus areas.

AI & Machine Learning Biotech Healthtech

Founders & leadership

Avenzoar Pharmaceuticals was founded in 2015 by Stephen Pandol.

Stephen PandolPresident, CMO & Co-Founder

Stephen ThesingChief Executive Officer

Joe NinoskyVP of Chemistry, Manufacturing, and Controls (CMC)

Terrance BruggemanNamed on SEC filing

Mouad EdderkaouiChief Scientific Officer & Co-Founder

David KramerNamed on SEC filing

William ReaveyNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$1.4M disclosed across 2 rounds · 2019–2023

▶$899.7KraisedJun 2023 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Mark ChinDirector
Shierley WidjajaDirector
Stephen PandolDirector
Mouad EdderkaouiDirector
Terrance J. BruggemanExecutive Officer, Director

Offering amount: $3M
Amount sold: $899.7K
Proceeds to insiders: $79.7K
First sale: May 2023
Incorporated: Corporation, California
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$525.1KraisedOct 2019 · 4 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Terrance BruggemanExecutive Officer, Director
Mouad EdderkaouiDirector
David KramerExecutive Officer
William ReaveyExecutive Officer

Offering amount: $918.2K
Amount sold: $525.1K
First sale: Oct 2019
Incorporated: Corporation, California, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Avenzo4 shared keywordsAvenzo Therapeutics is a clinical-stage biopharmaceutical company developing therapeutic treatments. The company focuses on oncology and cell therapy programs.

Companies competing with Avenzoar Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Avenzoar Pharmaceuticals do?: Avenzoar Pharmaceuticals is a pharmaceutical company developing therapies through its team of scientists and researchers. The page provides team information but limited detail on specific products or focus areas.
Who founded Avenzoar Pharmaceuticals?: Avenzoar Pharmaceuticals was founded by Stephen Pandol in 2015.
How much funding has Avenzoar Pharmaceuticals raised?: Avenzoar Pharmaceuticals has disclosed $1.4M raised across 2 rounds.
Where is Avenzoar Pharmaceuticals headquartered?: Avenzoar Pharmaceuticals is headquartered in Encinitas, US.